Pharmacologically active microcarriers: a tool for cell therapy

Pharmacologically active microcarriers: a tool for cell therapy
June 2005
V.M. Tatard, a, M.C. Venier-Julienne, a, P. Saulnier, a, E. Prechter, a, J.P. Benoit, a, P. Menei, a, b and C.N. Montero-Menei, a
aINSERM U 646, Laboratoire d?ing?nierie de la Vectorisation Particulaire, 10 rue Andr? Boquel, 49100 Angers, France
bService de Neurochirurgie, Centre Hospitalier Universitaire, 4 rue Larrey, 40033 Angers, France
Biomaterials Volume 26, Issue 17 , June 2005, Pages 3727-3737
ScienceDirect
You can view the abstract online. A subscription is required to view the full text or it can be purchased online.
Abstract
To overcome certain problems encountered in cell therapy, particularly cell survival, lack of cell differentiation and integration in the host tissue, we developed pharmacologically active microcarriers (PAM). These biodegradable particles made with poly(D,L-lactic-co-glycolic acid) (PLGA) and coated with adhesion molecules may serve as a support for cell culture and may be used as cell carriers presenting a controlled delivery of active protein. They can thus support the survival and differentiation of the transported cells as well as their microenvironment. To develop this tool, nerve growth factor (NGF)?releasing PAM, conveying PC12 cells, were produced and characterized. Indeed, these cells have the ability to differentiate into sympathetic?like neurons after adhering to a substrate, in the presence of NGF, and can then release large amounts of dopamine. Certain parameters such as the size of the microcarriers, the conditions enabling the coating of the microparticles and the subsequent adhesion of cells were thus studied to produce optimized PAM.